Skip to main content
Top
Published in: Inflammation Research 6/2011

01-06-2011 | Original Research Paper

Comparison of cardioprotective and anti-inflammatory effects of ischemia pre- and postconditioning in rats with myocardial ischemia–reperfusion injury

Authors: Jun Xiong, Qiang Wang, Fu-Shan Xue, Yuan-Jing Yuan, Shan Li, Jian-Hua Liu, Xu Liao, Yan-Ming Zhang

Published in: Inflammation Research | Issue 6/2011

Login to get access

Abstract

Objective

To compare cardioprotective and anti-inflammatory effects of ischemia preconditioning (IPC) and ischemia postconditioning (IPOC) in a rat myocardial ischemia–reperfusion injury (IRI) model.

Methods

Forty Sprague–Dawley rats were randomly divided equally into four groups. In the groups other than the sham group, the left anterior descending coronary artery was ligated for 30 min followed by a 180 min reperfusion in vivo. The control group was subjected to no additional intervention, the IPC group to three cycles of 5 min ischemia separated by 5 min reperfusion before the index ischemia and the IPOC group to three cycles of 10 s ischemia separated by 10 s reperfusion immediately after the end of the index ischemia. Hemodynamic changes during the ischemia and reperfusion were recorded. At 180 min of reperfusion, serum concentrations of troponin I (TnI), tumor necrosis factor α (TNF-α) and high-mobility group box 1 (HMGB-1) were assayed, and the infarction size was assessed by Evans blue and triphenyltetrazolium chloride staining.

Results

Compared to the control group, infarct size and serum concentrations of TnI, TNF-α and HMGB1 at 180 min of reperfusion were significantly reduced in the IPC and IPOC groups. However, infarct size and serum concentrations of TNF-α and HMGB1 at 180 min of reperfusion were significantly increased in the IPOC group compared to the IPC group.

Conclusions

In the rats with myocardial IRI in vivo, both IPC and IPOC can produce significant cardioprotective and anti-inflammatory effects. However, cardioprotective and anti-inflammatory effects provided by IPOC are weaker than with IPC.
Literature
2.
go back to reference Andreadou I, Iliodromitis EK, Koufaki M, Kremastinos DT. Pharmacological pre and postconditioning agents: reperfusion injury of the heart revisited. Mini Rev Med Chem. 2008;8:952–9.PubMedCrossRef Andreadou I, Iliodromitis EK, Koufaki M, Kremastinos DT. Pharmacological pre and postconditioning agents: reperfusion injury of the heart revisited. Mini Rev Med Chem. 2008;8:952–9.PubMedCrossRef
3.
go back to reference Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285:H579–88.PubMed Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285:H579–88.PubMed
4.
go back to reference Mockford KA, Girn HRS, Homer-Vanniasinkam S. Postconditioning: current controversies and clinical implications. Eur J Vasc Endovasc Surg. 2009;37:437–42.PubMedCrossRef Mockford KA, Girn HRS, Homer-Vanniasinkam S. Postconditioning: current controversies and clinical implications. Eur J Vasc Endovasc Surg. 2009;37:437–42.PubMedCrossRef
5.
go back to reference Sasaki H, Shimizu M, Ogawa K, Okazaki F, Taniguchi M, Taniguchi I, Mochizuki S. Brief ischemia-reperfusion performed after prolonged ischemia (ischemic postconditioning) can terminate reperfusion arrhythmias with no reduction of cardiac function in rats. Int Heart J. 2007;48:205–13.PubMedCrossRef Sasaki H, Shimizu M, Ogawa K, Okazaki F, Taniguchi M, Taniguchi I, Mochizuki S. Brief ischemia-reperfusion performed after prolonged ischemia (ischemic postconditioning) can terminate reperfusion arrhythmias with no reduction of cardiac function in rats. Int Heart J. 2007;48:205–13.PubMedCrossRef
6.
go back to reference Kin H, Zhao ZQ, Sun HY, Wang NP, Corvera JS, Halkos ME, Kerendi F, Guyton RA, Vinten-Johansen J. Postconditioning attenuates myocardial ischemia–reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res. 2004;62:74–85.PubMedCrossRef Kin H, Zhao ZQ, Sun HY, Wang NP, Corvera JS, Halkos ME, Kerendi F, Guyton RA, Vinten-Johansen J. Postconditioning attenuates myocardial ischemia–reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res. 2004;62:74–85.PubMedCrossRef
7.
go back to reference Hu X, Jiang H, Ma F, Xu C, Bo C, Wen H, Wu B, Lu Z. Similarities between ischemic preconditioning and postconditioning in myocardial ischemia/reperfusion injury. Int J Cardiol. 2009;144:135–6.PubMedCrossRef Hu X, Jiang H, Ma F, Xu C, Bo C, Wen H, Wu B, Lu Z. Similarities between ischemic preconditioning and postconditioning in myocardial ischemia/reperfusion injury. Int J Cardiol. 2009;144:135–6.PubMedCrossRef
8.
go back to reference Krisztina K, Csonka C, Bencsik P, Fodor G, Csont T, Ferdinandy P. The cardioprotective effect of postconditioning is lost in cholesterol diet-induced hyperlipidemia in rats. J Mol Cell Cardiol. 2006;40:976–7.CrossRef Krisztina K, Csonka C, Bencsik P, Fodor G, Csont T, Ferdinandy P. The cardioprotective effect of postconditioning is lost in cholesterol diet-induced hyperlipidemia in rats. J Mol Cell Cardiol. 2006;40:976–7.CrossRef
9.
go back to reference Iliodromitis EK, Zoga A, Vrettou A, Andreadou I, Paraskevaidis IA, Kaklamanis L, Kremastinos DT. The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits. Atherosclerosis. 2006;188:356–62.PubMedCrossRef Iliodromitis EK, Zoga A, Vrettou A, Andreadou I, Paraskevaidis IA, Kaklamanis L, Kremastinos DT. The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits. Atherosclerosis. 2006;188:356–62.PubMedCrossRef
10.
go back to reference Lee TM, Lin MS, Tsai CH, Chang NC. Effect of ischaemic preconditioning on regional release of inflammatory markers. Clin Sci (Lond). 2005;109:267–76.CrossRef Lee TM, Lin MS, Tsai CH, Chang NC. Effect of ischaemic preconditioning on regional release of inflammatory markers. Clin Sci (Lond). 2005;109:267–76.CrossRef
11.
go back to reference Vinten-Johansen J. Postconditioning: a mechanical maneuver that triggers biological and molecular cardioprotection responses to reperfusion. Heart Fail Rev. 2007;12(3–4):235–44.PubMedCrossRef Vinten-Johansen J. Postconditioning: a mechanical maneuver that triggers biological and molecular cardioprotection responses to reperfusion. Heart Fail Rev. 2007;12(3–4):235–44.PubMedCrossRef
12.
go back to reference Hiasa G, Hamada M, Ikeda S, Hiwada K. Ischemic preconditioning and lipopolysaccharide attenuate nuclear factor-κB activation and gene expression of inflammatory cytokines in the ischemia-reperfused rat heart. Jpn Circ J. 2001;65:984–90.PubMedCrossRef Hiasa G, Hamada M, Ikeda S, Hiwada K. Ischemic preconditioning and lipopolysaccharide attenuate nuclear factor-κB activation and gene expression of inflammatory cytokines in the ischemia-reperfused rat heart. Jpn Circ J. 2001;65:984–90.PubMedCrossRef
13.
go back to reference Kin H, Wang NP, Mykytenko J, Reeves J, Deneve J, Jiang R, Zatta AJ, Guyton RA, Vinten-Johansen J, Zhao ZQ. Inhibition of myocardial apoptosis by postconditioning is associated with attenuation of oxidative stress-mediated nuclear factor-κB translocation and TNFalpha release. Shock. 2008;29:761–8.PubMed Kin H, Wang NP, Mykytenko J, Reeves J, Deneve J, Jiang R, Zatta AJ, Guyton RA, Vinten-Johansen J, Zhao ZQ. Inhibition of myocardial apoptosis by postconditioning is associated with attenuation of oxidative stress-mediated nuclear factor-κB translocation and TNFalpha release. Shock. 2008;29:761–8.PubMed
14.
go back to reference Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol. 2005;5:331–42.PubMedCrossRef Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol. 2005;5:331–42.PubMedCrossRef
15.
go back to reference Lim SY, Davidson SM, Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore. Cardiovasc Res. 2007;75:530–5.PubMedCrossRef Lim SY, Davidson SM, Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore. Cardiovasc Res. 2007;75:530–5.PubMedCrossRef
16.
go back to reference Stumpner J, Redel A, Kellermann A, Lotz CA, Blomeyer CA, Smul TM, Kehl F, Roewer N, Lange M. Differential role of Pim-1 kinase in anesthetic-induced and ischemic preconditioning against myocardial infarction. Anesthesiology. 2009;111:125–64.CrossRef Stumpner J, Redel A, Kellermann A, Lotz CA, Blomeyer CA, Smul TM, Kehl F, Roewer N, Lange M. Differential role of Pim-1 kinase in anesthetic-induced and ischemic preconditioning against myocardial infarction. Anesthesiology. 2009;111:125–64.CrossRef
17.
go back to reference Ravingerova T, Pancza D, Ziegelhoffer A, Styk J. Preconditioning modulates susceptibility to ischemia-induced arrhythmias in the rats heart: the role of α-adrenergic stimulation and K (ATP) channels. Physiol Res. 2002;51:109–19.PubMed Ravingerova T, Pancza D, Ziegelhoffer A, Styk J. Preconditioning modulates susceptibility to ischemia-induced arrhythmias in the rats heart: the role of α-adrenergic stimulation and K (ATP) channels. Physiol Res. 2002;51:109–19.PubMed
18.
go back to reference Pourkhalili K, Hajizadeh S, Tiraihi T, Akbari Z, Esmailidehaj M, Bigdeli MR, Khoshbaten A. Ischemia and reperfusion-induced arrhythmias: role of hyperoxic preconditioning. J Cardiovasc Med (Hagerstown). 2009;10:635–42.CrossRef Pourkhalili K, Hajizadeh S, Tiraihi T, Akbari Z, Esmailidehaj M, Bigdeli MR, Khoshbaten A. Ischemia and reperfusion-induced arrhythmias: role of hyperoxic preconditioning. J Cardiovasc Med (Hagerstown). 2009;10:635–42.CrossRef
19.
go back to reference Vegh A, Komori S, Szekeres L, Parratt JR. Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats. Cardiovasc Res. 1992;26:487–95.PubMedCrossRef Vegh A, Komori S, Szekeres L, Parratt JR. Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats. Cardiovasc Res. 1992;26:487–95.PubMedCrossRef
20.
go back to reference Evrengul H, Seleci D, Tanriverdi H, Kaftan A. The antiarrhythmic effect and clinical consequences of ischemic preconditioning. Coron Artery Dis. 2006;17:283–8.PubMedCrossRef Evrengul H, Seleci D, Tanriverdi H, Kaftan A. The antiarrhythmic effect and clinical consequences of ischemic preconditioning. Coron Artery Dis. 2006;17:283–8.PubMedCrossRef
21.
go back to reference Matsubara T, Minatoguchi S, Matsuo H, Hayakawa K, Segawa T, Matsuno Y, Watanabe S, Arai M, Uno Y, Kawasaki M, Noda T, Takemura G, Nishigaki K, Fujiwara H. Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease. J Am Coll Cardiol. 2000;35:345–51.PubMedCrossRef Matsubara T, Minatoguchi S, Matsuo H, Hayakawa K, Segawa T, Matsuno Y, Watanabe S, Arai M, Uno Y, Kawasaki M, Noda T, Takemura G, Nishigaki K, Fujiwara H. Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease. J Am Coll Cardiol. 2000;35:345–51.PubMedCrossRef
22.
go back to reference Ren C, Gao X, Steinberg GK, Zhao H. Limb remote preconditioning protects against focal ischemia in rats and contradicts the dogma of therapeutic time windows for preconditioning. Neuroscience. 2008;151:1099–103.PubMedCrossRef Ren C, Gao X, Steinberg GK, Zhao H. Limb remote preconditioning protects against focal ischemia in rats and contradicts the dogma of therapeutic time windows for preconditioning. Neuroscience. 2008;151:1099–103.PubMedCrossRef
23.
go back to reference Loukogeorgakis SP, Williams R, Panagiotidou AT, Kolvekar SK, Donald A, Cole TJ, Yellon DM, Deanfield JE, MacAllister RJ. Transient limb ischemia induces remote preconditioning and remote postconditioning in humans by a KATP-channel dependent mechanism. Circulation. 2007;116:1386–95.PubMedCrossRef Loukogeorgakis SP, Williams R, Panagiotidou AT, Kolvekar SK, Donald A, Cole TJ, Yellon DM, Deanfield JE, MacAllister RJ. Transient limb ischemia induces remote preconditioning and remote postconditioning in humans by a KATP-channel dependent mechanism. Circulation. 2007;116:1386–95.PubMedCrossRef
24.
go back to reference Sodha NR, Clements RT, Feng J, Liu Y, Bianchi C, Horvath EM, Szabo C, Stahl GL, Sellke FW. Hydrogen sulfide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia/reperfusion injury. J Thorac Cardiovasc Surg. 2009;138:977–84.PubMedCrossRef Sodha NR, Clements RT, Feng J, Liu Y, Bianchi C, Horvath EM, Szabo C, Stahl GL, Sellke FW. Hydrogen sulfide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia/reperfusion injury. J Thorac Cardiovasc Surg. 2009;138:977–84.PubMedCrossRef
25.
go back to reference Schulz R. TNF-α in myocardial ischemia/reperfusion: damage vs. protection. J Mol Cell Cardiol. 2008;45:712–4.PubMedCrossRef Schulz R. TNF-α in myocardial ischemia/reperfusion: damage vs. protection. J Mol Cell Cardiol. 2008;45:712–4.PubMedCrossRef
26.
go back to reference Duran WN. The double-edge sword of TNF-alpha in ischemia–reperfusion injury. Am J Physiol Heart Circ Physiol. 2008;295:H2221–2.PubMedCrossRef Duran WN. The double-edge sword of TNF-alpha in ischemia–reperfusion injury. Am J Physiol Heart Circ Physiol. 2008;295:H2221–2.PubMedCrossRef
27.
go back to reference Li W, Sama AE, Wang H. Role of HMGB1 in cardiovascular diseases. Curr Opin Pharmacol. 2006;6:130–5.PubMedCrossRef Li W, Sama AE, Wang H. Role of HMGB1 in cardiovascular diseases. Curr Opin Pharmacol. 2006;6:130–5.PubMedCrossRef
28.
go back to reference Oozawa S, Mori S, Kanke T, Takahashi H, Liu K, Tomono Y, Asanuma M, Miyazaki I, Nishibori M, Sano S. Effects of HMGB1 on ischemia-reperfusion injury in the rat heart. Circ J. 2008;72:1178–84.PubMedCrossRef Oozawa S, Mori S, Kanke T, Takahashi H, Liu K, Tomono Y, Asanuma M, Miyazaki I, Nishibori M, Sano S. Effects of HMGB1 on ischemia-reperfusion injury in the rat heart. Circ J. 2008;72:1178–84.PubMedCrossRef
29.
go back to reference Andrassy M, Volz HC, Igwe JC, Funke B, Eichberger SN, Kaya Z, Buss S, Autschbach F, Pleger ST, Lukic IK, Bea F, Hardt SE, Humpert PM, Bianchi ME, Mairbaurl H, Nawroth PP, Remppis A, Katus HA, Bierhaus A. High-mobility group box-1 in ischemia–reperfusion injury of the heart. Circulation. 2008;117:3216–26.PubMedCrossRef Andrassy M, Volz HC, Igwe JC, Funke B, Eichberger SN, Kaya Z, Buss S, Autschbach F, Pleger ST, Lukic IK, Bea F, Hardt SE, Humpert PM, Bianchi ME, Mairbaurl H, Nawroth PP, Remppis A, Katus HA, Bierhaus A. High-mobility group box-1 in ischemia–reperfusion injury of the heart. Circulation. 2008;117:3216–26.PubMedCrossRef
30.
go back to reference Yu X, Patterson E, Huang S, Garrett MW, Kem DC. Tumor necrosis factor alpha, rapid ventricular tachyarrhythmias, and infarct size in canine models of myocardial infarction. J Cardiovasc Pharmacol. 2005;45:153–9.PubMedCrossRef Yu X, Patterson E, Huang S, Garrett MW, Kem DC. Tumor necrosis factor alpha, rapid ventricular tachyarrhythmias, and infarct size in canine models of myocardial infarction. J Cardiovasc Pharmacol. 2005;45:153–9.PubMedCrossRef
31.
go back to reference Reil JC, Gilles S, Zahler S, Brandl A, Drexler H, Hültner L, Matrisian LM, Welsch U, Becker BF. Insights from knock-out models concerning postischemic release of TNFalpha from isolated mouse hearts. J Mol Cell Cardiol. 2007;42:133–41.PubMedCrossRef Reil JC, Gilles S, Zahler S, Brandl A, Drexler H, Hültner L, Matrisian LM, Welsch U, Becker BF. Insights from knock-out models concerning postischemic release of TNFalpha from isolated mouse hearts. J Mol Cell Cardiol. 2007;42:133–41.PubMedCrossRef
32.
go back to reference McDonough JL, Arrell DK, Van Eky JE. Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury. Circ Res. 1999;84:9–20.PubMed McDonough JL, Arrell DK, Van Eky JE. Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury. Circ Res. 1999;84:9–20.PubMed
33.
go back to reference Kharbanda RK, Nielsen TT, Redington AN. Translation of remote ischaemic preconditioning into clinical practice. Lancet. 2009;374:1557–65.PubMedCrossRef Kharbanda RK, Nielsen TT, Redington AN. Translation of remote ischaemic preconditioning into clinical practice. Lancet. 2009;374:1557–65.PubMedCrossRef
Metadata
Title
Comparison of cardioprotective and anti-inflammatory effects of ischemia pre- and postconditioning in rats with myocardial ischemia–reperfusion injury
Authors
Jun Xiong
Qiang Wang
Fu-Shan Xue
Yuan-Jing Yuan
Shan Li
Jian-Hua Liu
Xu Liao
Yan-Ming Zhang
Publication date
01-06-2011
Publisher
SP Birkhäuser Verlag Basel
Published in
Inflammation Research / Issue 6/2011
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-010-0303-4

Other articles of this Issue 6/2011

Inflammation Research 6/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.